Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03819608 · ClinicalTrials.gov registry record · NA

Neuromodulation and Neurorehabilitation for mTBI

A NA study of Post Traumatic Stress Disorder and Mild Traumatic Brain Injury, sponsored by Northwestern University.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
2
Study locations

NCT03819608: Recruiting NA study of Post Traumatic Stress Disorder and Mild Traumatic Brain Injury, sponsored by Northwestern University.

NCT03819608 is a NA study of Post Traumatic Stress Disorder and Mild Traumatic Brain Injury that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 200 participants, below the 663-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (70% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03819608, a NA study of Post Traumatic Stress Disorder and Mild Traumatic Brain Injury, is actively recruiting participants, sponsored by Northwestern University.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
2
Study locations

Study Summary

This study will determine (i) the magnitude of immediate and sustained effects of a current clinical standard interactive computer attention processing training (APT) when combined with intermittent theta burst stimulation (iTBS), a type of repetitive transcranial magnetic stimulation and (ii) determine how APT + iTBS changes the neurocognitive system of attention in individuals with persistent attention deficits related to mTBI +/- PTSD.

Primary Outcome

Self-reported ability, adjustment and community participation. It is comprised of 30 items and three subscales: Ability Index, Adjustment Index and Participation Index. Items are scored on a 5-point Likert scale, with lower scores indicating higher levels of functioning.

Conditions Studied

Post Traumatic Stress Disorder Mild Traumatic Brain Injury

Interventions

  • DEVICE real iTBS
  • BEHAVIORAL real APT
  • BEHAVIORAL placebo APT
  • DEVICE placebo iTBS

Study Locations (2)

Illinois

  • Northwestern University - Chicago

Texas

  • Moody Neurorehabilitation Institute - Houston

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2021-04-01
Est. Completion 2025-12
Phase NA
Northwestern University

1,209 total trials

What NCT03819608 shows while recruiting

NCT03819608 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 663-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (70% lower).

The record links to 2 conditions, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 4 interventions - of which real iTBS is the first listed.

NCT03819608 reports a single indexed study location in Illinois, Texas.

Frequently Asked Questions

What is clinical trial NCT03819608 about?

NCT03819608 is a clinical study titled "Neuromodulation and Neurorehabilitation for mTBI". This study will determine (i) the magnitude of immediate and sustained effects of a current clinical standard interactive computer attention processing training (APT) when combined with intermittent theta burst stimulation (iTBS), a type of repetitive transcranial magnetic stimulation and (ii) deter...

What is the current status of trial NCT03819608?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2021-04-01. Estimated completion is 2025-12.

What conditions does trial NCT03819608 study?

This clinical trial studies the following conditions: Post Traumatic Stress Disorder, Mild Traumatic Brain Injury.

What interventions are being tested in trial NCT03819608?

The interventions under investigation include: real iTBS (DEVICE), real APT (BEHAVIORAL), placebo APT (BEHAVIORAL), placebo iTBS (DEVICE).

Who is sponsoring clinical trial NCT03819608?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03819608 being conducted?

This trial has 2 study locations across Illinois, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Post Traumatic Stress Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03819608's enrollment target sits among peer trials

200 47th of 262 higher than 207 of 262 other Post Traumatic Stress Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT03819608

Source: ClinicalTrials.gov NCT03819608, the US trial registry maintained by the National Library of Medicine. NCT03819608 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.